ICAM-1 plays a crucial role in facilitating the adhesion of immune cells to the tumour site, and its reduced expression can hinder the recruitment and activation of antitumour immune cells, thereby allowing the tumour to evade immune surveillance and continue to progress [85]. The gene discussed is ICAM1; the disease is neoplasm.